US Archives - Page 146 of 201 - European Medical Journal

AMJ Dermatology 2 [Supplement 1] 2025

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

New Clinical Guidelines for Managing Central Airway Obstruction

Clinical practice guidelines providing critical recommendations for managing central airway obstruction (CAO), a condition linked to poor prognosis in both malignant and nonmalignant airway diseases, have recently been published.

What Are Best Next Steps After JAKi Failure?

For patients with rheumatoid arthritis (RA) with an inadequate response to Janus kinase inhibitors (JAKi), new research suggests that cycling to another JAKi may be more effective than switching to a biologic disease-modifying anti-rheumatic drug (bDMARD).

Statins Linked to Better Immune Checkpoint Inhibitor Outcomes

A recent meta-analysis suggests that statin use is associated with improved survival outcomes in patients with cancer undergoing immune checkpoint inhibitor (ICI) therapy.

Twice-Yearly HIV Prevention Shot Nears FDA Decision

The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the first-ever twice-yearly injectable HIV prevention therapy.

New Therapy Hope for Hard-to-Treat DLBCL

A new treatment combination has emerged for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplant (ASCT).

The Surprising Link Between Almond Consumption and Gut Health

Almond consumption and gut health may be linked and demonstrate the role of the microbiome in cardiometabolic health, according to a recent review.

The Evolution of Tuberculosis Isolation Practices

A new study explores the evolution of tuberculosis isolation, from early misconceptions to modern airborne transmission guidelines. See how TB control measures have changed.

Navigating Challenges in Cardiac Device Infections

Cardiac implantable electronic device infections (CIEDIs) pose significant challenges in diagnosis and management for healthcare professionals.

Do Obesity, Diabetes, Smoking Affect Surgical Outcomes in Hidradenitis Suppurativa?

A recently published review examined the impact of obesity, diabetes, and smoking on surgical outcomes for patients with hidradenitis suppurativa (HS).